Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Galera Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues18.720.6
            Revenue growth-9.4% 
Cost of goods sold37.341.2
Gross profit-18.7-20.6
            Gross margin-100.0%-100.0%
General and administrative5.63.5
EBIT-24.3-24.1
            EBIT margin-130.0%-117.0%
Pre-tax income-23.9-23.9
Income taxes-0.2-0.4
            Tax rate0.9%1.5%
Net income0.00.0
            Net margin-0.2%-0.1%
 
Diluted EPS($98.42)($93.59)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy